Frost & Sullivan supports Breast Cancer Awareness Month and research with its latest analysis, Global Breast Ultrasound Market, Forecast to 2023. Mammography is widely used for breast cancer screening; ultrasound is used as a supplemental screening for patients at high risk and for those who have conspicuous findings in a mammogram. The market for conventional handheld ultrasound has performed well as a supplemental imaging in most countries and primary diagnostic/screening tool in others. As of 2018, Frost & Sullivan estimates that among all medical imaging equipment, the breast ultrasound segment has reached 85% market penetration in the United States, 50%-60% in Western Europe and Japan, and between 20%-30% in the Rest of World.
The global market for breast ultrasound systems is expected to grow from $1.11 billion in 2018 to $1.71 billion by 2023. This expansion is largely driven by the use of novel techniques, machine learning, and deep-learning algorithms to deliver high-quality imaging and digital capabilities such as cloud and data analytics.
